1014 related articles for article (PubMed ID: 16952668)
1. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
Stovsky MD; Griffiths RI; Duff SB
J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
[TBL] [Abstract][Full Text] [Related]
2. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
Rosario DJ; Phillips JT; Chapple CR
J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
[TBL] [Abstract][Full Text] [Related]
3. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
Goh AC; Gonzalez RR
J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
[TBL] [Abstract][Full Text] [Related]
4. The early postoperative morbidity of transurethral resection of the prostate and of 4 minimally invasive treatment alternatives.
Schatzl G; Madersbacher S; Lang T; Marberger M
J Urol; 1997 Jul; 158(1):105-10; discussion 110-1. PubMed ID: 9186334
[TBL] [Abstract][Full Text] [Related]
5. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized 1-year clinical trial comparing transurethral needle ablation to transurethral resection of the prostate for the treatment of symptomatic benign prostatic hyperplasia.
Bruskewitz R; Issa MM; Roehrborn CG; Naslund MJ; Perez-Marrero R; Shumaker BP; Oesterling JE
J Urol; 1998 May; 159(5):1588-93; discussion 1593-4. PubMed ID: 9554360
[TBL] [Abstract][Full Text] [Related]
7. Holmium laser ablation of the prostate versus photoselective vaporization of prostate 60 cc or less: short-term results of a prospective randomized trial.
Elzayat EA; Al-Mandil MS; Khalaf I; Elhilali MM
J Urol; 2009 Jul; 182(1):133-8. PubMed ID: 19447438
[TBL] [Abstract][Full Text] [Related]
8. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
Yu X; Elliott SP; Wilt TJ; McBean AM
J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
[TBL] [Abstract][Full Text] [Related]
9. Holmium laser ablation versus photoselective vaporization of prostate less than 60 cc: long-term results of a randomized trial.
Elmansy HM; Elzayat E; Elhilali MM
J Urol; 2010 Nov; 184(5):2023-8. PubMed ID: 20850828
[TBL] [Abstract][Full Text] [Related]
10. Impact of interventional therapy for benign prostatic hyperplasia on quality of life and sexual function: a prospective study.
Arai Y; Aoki Y; Okubo K; Maeda H; Terada N; Matsuta Y; Maekawa S; Ogura K
J Urol; 2000 Oct; 164(4):1206-11. PubMed ID: 10992367
[TBL] [Abstract][Full Text] [Related]
11. KTP/LBO laser vaporization of the prostate.
Wosnitzer MS; Rutman MP
Urol Clin North Am; 2009 Nov; 36(4):471-83, vi. PubMed ID: 19942046
[TBL] [Abstract][Full Text] [Related]
12. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial comparing transurethral resection of the prostate, laser therapy and conservative treatment of men with symptoms associated with benign prostatic enlargement: The CLasP study.
Donovan JL; Peters TJ; Neal DE; Brookes ST; Gujral S; Chacko KN; Wright M; Kennedy LG; Abrams P
J Urol; 2000 Jul; 164(1):65-70. PubMed ID: 10840426
[TBL] [Abstract][Full Text] [Related]
14. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
DiSantostefano RL; Biddle AK; Lavelle JP
BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
[TBL] [Abstract][Full Text] [Related]
16. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
Yu B; Wang Z
Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
[TBL] [Abstract][Full Text] [Related]
17. Photoselective vaporization of prostate: five-year outcomes of entire clinic patient population.
Hai MA
Urology; 2009 Apr; 73(4):807-10. PubMed ID: 19200589
[TBL] [Abstract][Full Text] [Related]
18. Photoselective vaporization for benign prostatic hyperplasia.
Murtagh J; Foerster V
Issues Emerg Health Technol; 2006 Dec; (95):1-4. PubMed ID: 17176529
[TBL] [Abstract][Full Text] [Related]
19. The effects of transurethral needle ablation and resection of the prostate on pressure flow urodynamic parameters: analysis of the United States randomized study.
Roehrborn CG; Burkhard FC; Bruskewitz RC; Issa MM; Perez-Marrero R; Naslund MJ; Shumaker BP
J Urol; 1999 Jul; 162(1):92-7. PubMed ID: 10379748
[TBL] [Abstract][Full Text] [Related]
20. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
